The Initiation of Meiotic Sex Chromosome Inactivation Sequesters DNA Damage Signaling from Autosomes in Mouse Spermatogenesis.
Abe, H; Alavattam, KG; Hu, Y; Pang, Q; Andreassen, PR; Hegde, RS; Namekawa, SH.
Current Biology.
2020;
30:408-420.e5.
NF1 patient missense variants predict a role for ATM in modifying neurofibroma initiation.
Yu, Y; Choi, K; Wu, J; Andreassen, PR; Dexheimer, PJ; Keddache, M; Brems, H; Spinner, RJ; Cancelas, JA; Martin, LJ; et al.
Acta Neuropathologica.
2020;
139:157-174.
CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites.
Jayavaradhan, R; Pillis, DM; Goodman, M; Zhang, F; Zhang, Y; Andreassen, PR; Malik, P.
Nature Communications.
2019;
10.
SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints.
Dong, Y; Zhao, X; Feng, X; Zhou, Y; Yan, X; Zhang, Y; Bu, J; Zhan, D; Hayashi, Y; Zhang, Y; et al.
Leukemia.
2019;
33:2585-2598.
Deficiency of the Fanconi anemia E2 ubiqitin conjugase UBE2T only partially abrogates Alu-mediated recombination in a new model of homology dependent recombination.
Lewis, TW; Barthelemy, JR; Virts, EL; Kennedy, FM; Gadgil, RY; Wiek, C; Linka, RM; Zhang, F; Andreassen, PR; Hanenberg, H; et al.
Nucleic Acids Research.
2019;
47:3503-3520.
XRCC2 (X-ray repair cross complementing 2).
Andreassen, PR; Hanenberg, H.
Atlas of genetics and cytogenetics in oncology and haematology.
2019;
23:1-7.
PALB2 (partner and localizer of BRCA2).
Hanenberg, H; Andreassen, PR.
Atlas of genetics and cytogenetics in oncology and haematology.
2018;
22:484-490.
DNA repair-related functional assays for the classification of BRCA1 and BRCA2 variants: a critical review and needs assessment.
Toland, AE; Andreassen, PR.
Journal of Medical Genetics.
2017;
54:721-731.
Elucidation of the Fanconi Anemia Protein Network in Meiosis and Its Function in the Regulation of Histone Modifications.
Alavattam, KG; Kato, Y; Sin, H; Maezawa, S; Kowalski, IJ; Zhang, F; Pang, Q; Andreassen, PR; Namekawa, SH.
Cell Reports.
2016;
17:1141-1157.
Complementation of hypersensitivity to DNA interstrand crosslinking agents demonstrates that XRCC2 is a Fanconi anaemia gene.
Park, J; Virts, EL; Jankowska, A; Wiek, C; Othman, M; Chakraborty, SC; Vance, GH; Alkuraya, FS; Hanenberg, H; Andreassen, PR.
Journal of Medical Genetics.
2016;
53:672-680.